BEIJING, Oct. 15, 2021 /PRNewswire/ -- Concord Medical
Services Holdings Limited ("Concord Medical" or the "Company")
(NYSE: CCM), a healthcare provider specialized in cancer
treatment, research, education and prevention by establishing
proton centers, premium cancer hospitals, and specialty cancer
hospitals and operating an extensive network of
radiotherapy and diagnostic imaging centers in China, today
announced that it filed its annual report on Form 20-F for the
fiscal year ended December 31, 2020 (the "Annual Report")
with the U.S. Securities and Exchange Commission. An electronic
copy of the Annual Report can be accessed on Concord Medical's
investor relations website
at http://ir.ccm.cn and on the SEC's
website at www.sec.gov. Shareholders may receive a hard
copy of the Annual Report free of charge upon request. Requests
should be submitted to http://ir.ccm.cn.
About Concord Medical
Concord Medical Services Holdings Limited is a healthcare
provider specialized in cancer treatment, research, education
and prevention. The Company operates a network of medically
advanced comprehensive cancer hospitals and standalone radiotherapy
and diagnostic imaging centres in China. The Company focuses
on providing multidisciplinary cancer care approach in all areas of
oncology services in its cancer hospitals. The Company is also
establishing proton centers, premium cancer hospitals, and
specialty cancer hospitals. In October
2020, the company completed the construction of Guangzhou
Concord Cancer Center, which is expected to be in operation in
June 2021. The Company also equips
its hospitals with technologically advanced equipment such as the
state-of-the-art proton therapy system in
its Beijing, Shanghai and Guangzhou cancer
hospitals. In addition, the Company saw the opportunity of the
expanding market of medical equipment in China and developed its product life-cycle
management services form its existing medical equipment and
consumable sales services. As of December 31, 2020, the
Company operated a network of 27 radiotherapy centers and
diagnostic imaging centers, which are based in 20 hospitals,
established under long-term lease and management services
arrangements with the Company and spanning over 20 cities
across 13 provinces and administrative regions in China. To
ensure the commitment to the highest standard of medical
services for patients, the Company offers ongoing education
and training for doctors and other medical professionals in its
network hospitals and centres in both domestic and overseas medical
institutions. For more information, please
see http://ir.ccm.cn.
View original
content:https://www.prnewswire.com/news-releases/concord-medical-files-2020-annual-report-on-form-20-f-301401478.html
SOURCE Concord Medical Services Holdings Limited